ISL
NPTN

Ingalls & Snyder LLC’s NEOPHOTONICS CORP NPTN Stock Holding History

Ingalls & Snyder LLC’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,000
Closed -$123K – 438
2020
Q1 		$123K Buy
+17,000
New +$126K 0.01% 385

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ingalls & Snyder LLC's NPTN Position: Q2 2020 in Review

Ingalls & Snyder LLC sold out of NEOPHOTONICS CORP (NPTN) in Q2 2020, closing a stake of 17,000 shares — an estimated $123K sold.

Ingalls & Snyder LLC first reported a position in NPTN in Q1 2020 and held it in 1 quarter. The position peaked at $123K in Q1 2020. 163 funds tracked by Wall St. Rank hold NPTN as of Q2 2020.

  • Ingalls & Snyder LLC reported no remaining NEOPHOTONICS CORP position as of Q2 2020 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 17,000 NEOPHOTONICS CORP shares in Q2 2020, an estimated $123K.
  • Ingalls & Snyder LLC first reported a position in NEOPHOTONICS CORP in Q1 2020 and held it in 1 quarter.
  • Ingalls & Snyder LLC's NEOPHOTONICS CORP position peaked at $123K in Q1 2020.
  • 163 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2020.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2020, filed 31 Jul 2020.